AstraZeneca
AstraZeneca in strategic R&D collaboration with UK Medical Research Council
01 April 2014
AstraZeneca completes buy-out of Sumitomo Chemical’s stake in AstraZeneca KK
26 March 2014
AstraZeneca confirms de-listing from Indian bourses
19 March 2014
AstraZeneca to acquire Bristol-Myers Squibb’s stake in diabetes business
20 December 2013
S Korean companies Hanmi and Amneal Pharm launch first copy of AstraZeneca's Nexium in US
20 December 2013
AstraZeneca to buy biotech company Spirogen in $440 mn deal
15 October 2013
AstraZeneca to acquire respiratory drug company Pearl Therapeutics in $1.15 bn deal
10 June 2013
AstraZeneca's withdrawal of drug from regulatory tests hits partner Rigel's shares
05 June 2013
AstraZeneca site to emerge as biotech hub
08 May 2013
AstraZeneca in $200-mn cancer drug development deal with Bind Therapeutics
22 April 2013
AstraZeneca’s rheumatoid arthritis pill fostamatinib shows mixed results in trial
08 April 2013
AstraZeneca settles Crestor lawsuit with Egis and Actavis
25 March 2013
AstraZeneca to eliminate 1,600 jobs in major R&D restructuring
19 March 2013
AstraZeneca chief hints at changes with adverse outlook as patents expire
02 February 2013
AstraZeneca loses appeal on lung cancer drug rights in India
28 November 2012
AstraZeneca to pay Bristol-Myers Squibb $135 mn more for Amylin drug rights
10 August 2012
Bristol-Myers Squibb, AstraZeneca expand alliance through Amylin acquisition
30 June 2012
AstraZeneca Q1 profit slumps; CEO quits
27 April 2012
AstraZeneca eliminates 7,300 jobs in major restructuring
03 February 2012
AstraZeneca to buy China’s generic maker Guangdong BeiKang Pharma
08 December 2011
AstraZeneca to cut 1,150 sales jobs in the US
08 December 2011
AstraZeneca - Bristol-Myers to present new data on diabetes drug
27 October 2011
AstraZeneca close to selling dental implants unit to Dentsply for $1.8 billion: report
21 June 2011
Russia, China precede India for AstraZeneca's expansion plans
18 June 2011
AstraZeneca to pay $250,000 to 124 women for sex discrimination
07 June 2011
AstraZeneca, Daiichi Sankyo to promote Amgen's new bone cancer drug
24 May 2011
AstraZeneca saves over $1 billion in tax dispute settlement
28 March 2011
AstraZeneca to pay $198 million to settle 17,500 Seroquel lawsuits
09 August 2010
AstraZeneca scrip slumps after buy-back offer
07 July 2010
AstraZeneca settles US drug pricing suit for $103 million
19 June 2010
AstraZeneca settles Seroquel case with US government for $520 million
28 April 2010
AstraZeneca, Bristol-Myers Squibb in diabetes research alliance
01 April 2010
Torrent in AstraZeneca's debut deal to sell branded generics
11 March 2010
AstraZeneca settles UK tax dispute with £505 million payout
24 February 2010
AstraZeneca India to pay 500 per cent dividend
23 February 2010
AstraZeneca inks arthritis drug deal with Rigel
16 February 2010
US FDA approves AstraZeneca's Crestor
09 February 2010
AstraZeneca reports profit, cuts 8,000 jobs to cut costs
29 January 2010
AstraZeneca settles another Nexium patent litigation for US sales
07 January 2010
AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs
24 December 2009
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
AstraZeneca, Merck & Co to in phase 1 cancer drug research
01 June 2009
Jubilant signs research deal with Anglo-Swedish firm AstraZeneca
06 May 2009
Infosys wins multi-million dollar AstraZeneca deal
15 December 2008
AstraZeneca, Abraxis rethink cancer drug deal
26 November 2008
AstraZeneca agrees to cut drug prices in UK, stock plummets
20 November 2008
Fish oil better than AstraZeneca's Crestor says new heart-failure study
01 September 2008
US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel
03 July 2008
Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US
15 April 2008
AstraZeneca forms clinical research venture with private equity firms
18 February 2008
AstraZeneca acquires paediatric asthma development programmes from Verus Pharmaceuticals
25 September 2007
AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion
28 April 2007
Global collaboration to develop new anti-obesity compounds
02 February 2007
Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement
24 November 2005
AstraZeneca sues Ranbaxy on Nexium patent
22 November 2005
AstraZeneca to drop Viozan
29 June 2001
AstraZeneca launches $ 100 million facility in China
30 April 2001
AstraZeneca to acquire development rights from Cyclacel
17 April 2001
AstraZeneca sells off speciality chemicals
13 May 1999
Cheminor unfazed by AstraZeneca patent infringement suit
13 May 1999
 search domain-b
  go